Discover how the Dexter microfluidic platform is transforming cancer research by enabling unprecedented observation of tumor-immune interactions in microdroplets.
Exploring how cancer research is revolutionizing treatment for RASopathies, a family of rare genetic disorders affecting the RAS/MAPK pathway.
Discover how a novel 8-gene signature combining hypoxia and immune regulation predicts survival across six cancer types, starting with liver cancer.
Exploring the dual roles of proto-oncogenes in development and cancer, with insights into RET signaling and therapeutic implications.
Discover how computational biology and the Galaxy framework are revolutionizing cancer biomarker discovery through in silico strategies.
Exploring how proteomics is revolutionizing cancer detection and treatment through protein analysis and biomarker discovery.